GSK plc Cost Of Sales
GSK plc (GLAXF) reported Cost Of Sales of GBP 9.02 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-06.
Financial Statements › Expense Statement › Cost of Sales
ifrs-full:CostOfSales · last filed 2026-03-06
| Period end | Cost Of Sales 12 month | Cost Of Sales 12 month as first filed |
|---|---|---|
| 2025-12-31 | 9.02B GBP 20-F · filed 2026-03-06 | |
| 2024-12-31 | 9.05B GBP 20-F · filed 2026-03-06 | |
| 2023-12-31 | 8.56B GBP 20-F · filed 2026-03-06 | |
| 2022-12-31 | 9.55B GBP 20-F · filed 2025-03-03 | |
| 2021-12-31 | 8.16B GBP 20-F · filed 2024-03-05 | 11.60B GBP 20-F · filed 2022-03-08 |
| 2020-12-31 | 7.93B GBP 20-F · filed 2023-03-10 | 11.70B GBP 20-F · filed 2021-03-12 |
| 2019-12-31 | 11.86B GBP 20-F · filed 2022-03-08 | |
| 2018-12-31 | 10.24B GBP 20-F · filed 2021-03-12 | |
| 2017-12-31 | 10.34B GBP 20-F · filed 2020-03-06 | |
| 2016-12-31 | 9.29B GBP 20-F · filed 2019-03-15 | |
| 2015-12-31 | 8.85B GBP 20-F/A · filed 2018-03-20 |